Stockreport

Relay Therapeutics (RLAY) Is Up 30.6% After Expanding Zovegalisib Into Vascular Anomalies Data Reveal [Yahoo! Finance]

Relay Therapeutics, Inc.  (RLAY) 
PDF presented at the International Society for the Study of Vascular Anomalies World Congress 2026 in May. This update highlights how Relay is extending zovegalisib beyond [Read more]